The U.S. federal government has recently awarded the following notable contract related to the field of chemical, biological, radiological and nuclear (CBRN) equipment or life science research of interest for potential applications in biodefense:
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, was awarded a cost-plus-fixed-fee contract for advanced development of gamma-tocotrienol as a radiation countermeasure.
The contract is valued at $7,777,466. Work will be performed in Bethesda, Maryland, with an estimated completion date of Sept. 20, 2019.
Bids were solicited via the Internet with 45 received. Fiscal 2014 and 2015 research, development, testing and evaluation funds in the amount of $7,777,466 were obligated at the time of the award.
The Army Medical Research Acquisition Activity, Frederick, Maryland, is the contracting activity (W81XWH-15-C-0117).
The not-for-profit Henry M. Jackson Foundation is authorized by Congress to support research at the Uniformed Services University of the Health Sciences (USU) and throughout military medicine. Since its founding in 1983, HJF has served as a vital link between the military medical community and its federal and private partners.
Source: Defense.gov, HJF
